Urologic Cancers
A urologic cancer diagnosis can be devastating. Our dedicated team of experts takes an integrated, patient-centered approach to diagnose and treat prostate, kidney, bladder and testicular cancer to ensure optimal outcomes with minimal impact on your quality of life. Contact us for a consultation.
As a National Cancer Institute-designated comprehensive cancer center, City of Hope’s urology and urologic oncology program is uniquely positioned to provide personalized and comprehensive treatment plans, along with access to groundbreaking clinical trials.
City of Hope is a nationally recognized leader in researching and treating urologic cancers.
Our Urologic Oncology Program Highlights:
- Advanced imaging technologies that can accurately pinpoint a tumor’s size, shape and location, enhancing our doctors’ detection and treatment planning capabilities, as well as better monitoring of “active surveillance” patients
- Minimally invasive and robotically assisted surgical techniques that can offer optimal outcomes with less pain, reduced scarring and faster healing time
- Targeted radiation regimens that are sculpted to the size and shape of the tumor, focusing its impact on cancer cells while minimizing exposure to nearby normal tissues
- A drug development pipeline that quickly identifies new cancer drugs and turns them into promising therapies for clinical trials
- Access to innovative clinical trials that target specific stages of the cancer spectrum Enhanced urinary diversion techniques that minimize interference with everyday life
- Leading expertise in complex surgery and reconstruction
Additionally, City of Hope patients have access to our extensive team of supportive care and survivorship experts, who will help you and your caregivers achieve and maintain a better quality of life during and after your urologic cancer treatment.
City of Hope is one of the few facilities designated a comprehensive cancer center by the National Cancer Institute.
Our developments in the areas of breakthrough cancer drugs, bone marrow transplants and CAR T cell therapy are recognized internationally.
Our leadership in research and innovation continually enhances our ability to provide novel and differentiated approaches to cancer care.
